Conversely, other reports indicate that MSCs can promote CRC progression by enhancing angiogenesis and epithelial–mesenchymal transition (EMT) and by supporting cancer stemness and metastasis, partly through TGF-β and cancer-associated fibroblast (CAF)-like differentiation [7,8]. This evidence concerns the gene TGFB1 and cancer.